بدائل البحث:
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
facies decrease » largest decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
facies decrease » largest decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
-
561
-
562
-
563
-
564
-
565
-
566
Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups.
منشور في 2024الموضوعات: -
567
-
568
Comparison of myocardial LC3 immunofluorescence staining of three groups (×400, scale bar = 10μm).
منشور في 2024الموضوعات: -
569
-
570
-
571
Comparison of Beclin1, P62 and LC3B(II/I) protein expression levels in three groups.
منشور في 2024الموضوعات: -
572
-
573
Flowchart of the screening process.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
574
Result of the AMSTAR-2 assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
575
Characteristics of included reviews.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
576
Result of the PRISMA assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
577
Result of the ROBIS assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
578
Decreased virulence observed during <i>in planta</i> infection with <i>ΔFgknr4</i>.
منشور في 2025"…In wheat inoculated with <i>ΔFgknr4</i> compared to WT, decreased host colonisation is observed, evidenced by (i) reduced fungal hyphae proliferation, particularly in the thicker adaxial cell layer, (ii) collapsed air spaces in wheat cells, and (iii) increased polymer deposition at the wheat cell walls (black arrows), indicating an enhanced defence response. …"
-
579
-
580
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…(F-G) Representative western blots and summarized bar graph showed EVO significantly increased protein expression of SM22α and decreased RUNX2 in CER treated P<sub>i</sub>-induced VSMCs. …"